Parathyroid

LATEST

Bone Metabolism Etelcalcetide Examined in Hemodialysis Patients With Secondary Hyperparathyroidism

Etelcalcetide Examined in Hemodialysis Patients With Secondary Hyperparathyroidism

Etelcalcetide shows promise for reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.

Bone Metabolism

VIDEO: Clinical Trial Results for Abaloparatide

Lorraine Fitzpatrick, MD, discusses updated results from the ACTIVE phase 3 clinical trial.

Bone Metabolism

New Osteoporosis Treatment Options on the Horizon

Nancy E. Lane, MD, professor of medicine, at the University of California at Davis School of Medicine, discusses results from the phase 3 ACTIVE trial.

Bone Metabolism Risk for Secondary Hyperparathyroidism Up With Furosemide Use

Risk for Secondary Hyperparathyroidism Up With Furosemide Use

Study reveals 6-fold higher risk of secondary hyperparathyroidism in patients on furosemide vs hydrochlorothiazide.

Bone Metabolism Long-Term rhPTH(1-84) Associated With Reduced Need for Calcium, Calcitriol Supplements

Long-Term rhPTH(1-84) Associated With Reduced Need for Calcium, Calcitriol Supplements

The therapy was also associated with reduced urinary calcium excretion and stable serum calcium concentration in patients with hypoparathyroidism.

Bone Metabolism Parathyroidectomy Improves Quality of Life in Primary Hyperparathyroidism

Parathyroidectomy Improves Quality of Life in Primary Hyperparathyroidism

Quality-of-life scores improved significantly after successful parathyroidectomy.

Bone Metabolism Parathyroidectomy May Reduce Fracture Risk in Primary Hyperparathyroidism

Parathyroidectomy May Reduce Fracture Risk in Primary Hyperparathyroidism

Reduced fracture risk for surgery; bisphosphonate treatment no better than observation

Bone Metabolism Parathyroidectomy Bested Cinacalcet for Hyperparathyroidism After Kidney Transplant

Parathyroidectomy Bested Cinacalcet for Hyperparathyroidism After Kidney Transplant

Recent data showed that parathyroidectomy is more effective for controlling hypercalcemia after kidney transplants in patients with persistent hyperparathyroidism.

Bone Metabolism Chronic Proton Pump Inhibitor Exposure Tied to Hyperparathyroidism in Elderly

Chronic Proton Pump Inhibitor Exposure Tied to Hyperparathyroidism in Elderly

The correlation persists regardless of concurrent oral bisphosphonate administration.

Bone Metabolism Parathyroid Hormone for Hypoparathyroidism May Be Effective Over Long Term

Parathyroid Hormone for Hypoparathyroidism May Be Effective Over Long Term

PTH (1-84) for 7 years is linked to reduced calcium and calcitriol supplementation.

Bone Metabolism Parathyroidectomy May Decrease Mortality Risk in Secondary Hyperparthyroidism

Parathyroidectomy May Decrease Mortality Risk in Secondary Hyperparthyroidism

Hemodialysis patients who undergo the procedure experience decreased risks of all-cause and cardiovascular mortality.

Bone Metabolism Effects of Cyclic vs. Daily Teriparatide on BMD in Osteoporosis

Effects of Cyclic vs. Daily Teriparatide on BMD in Osteoporosis

Cyclic treatment with teriparatide yields improvements in bone mineral density that are similar to daily treatment in women taking alendronate.

Bone Metabolism Natpara Injection Now Available in the U.S.

Natpara Injection Now Available in the U.S.

Shire announced the launch of Natpara (parathyroid hormone) for injection indicated as adjunct to calcium and vitamin D to control hypocalcemia in patients with hypoparathyroidism

Bone Metabolism Natpara Earns FDA Approval for Hypoparathyroidism

Natpara Earns FDA Approval for Hypoparathyroidism

The FDA has approved Natpara (parathyroid hormone) to control hypocalcemia in patients with hypoparathyroidism.

Bone Metabolism Advisory Panel Favors Approval of Natpara

Advisory Panel Favors Approval of Natpara

The FDA's Endocrinologic and Metabolic Drugs Advisory Committee voted to recommend approval of recombinant human parathyroid hormone for hypoparathyroidism.

Bone Metabolism Dementia Linked to Parathyroid Hormone

Dementia Linked to Parathyroid Hormone

Elevated parathyroid hormone levels may play a role in the development of vascular dementia.

Bone Metabolism Primary Hyperparathyroidism Screening Needs Improvement

Primary Hyperparathyroidism Screening Needs Improvement

More patients with abnormal bone mineral density should undergo screening for primary hyperparathyroidism.

Bone Metabolism Recombinant Human Parathyroid Hormone Effective for Hypoparathyroidism

Recombinant Human Parathyroid Hormone Effective for Hypoparathyroidism

Patients with hypoparathyroidism may benefit from treatment with recombinant human parathyroid hormone.

Bone Metabolism AMG 416 Succeeds in Secondary Hyperparathyroidism Trial

AMG 416 Succeeds in Secondary Hyperparathyroidism Trial

AMG 416 demonstrated positive results for the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.

Bone Metabolism Elevated Parathyroid Hormone Linked to Heart Failure Risk

Elevated Parathyroid Hormone Linked to Heart Failure Risk

Risk for heart failure appeared to be increased with elevated parathyroid hormone levels.

Bone Metabolism Parathyroid Hormone Predicts Vitamin D's Effect on Glucose Metabolism

Parathyroid Hormone Predicts Vitamin D's Effect on Glucose Metabolism

Levels of parathyroid hormone (PTH) should be considered when evaluating the effect of vitamin D status on glucose metabolism.

Sign Up for Free e-Newsletters